甲状腺活动功能与冠状动脉粥样硬化关系的双向孟德尔随机化分析。

IF 1.9 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Reviews in cardiovascular medicine Pub Date : 2024-12-24 eCollection Date: 2024-12-01 DOI:10.31083/j.rcm2512453
Le-Tai Li, Jia-Jie Leng, Yu-Xiang Luo, Rong-Jia Liu, Zhuo-Xuan Song, Meng Ye, Zhen-Han Li, Zhen-Rui Cao, Ying-Jiu Jiang, Hong-Tao Tie
{"title":"甲状腺活动功能与冠状动脉粥样硬化关系的双向孟德尔随机化分析。","authors":"Le-Tai Li, Jia-Jie Leng, Yu-Xiang Luo, Rong-Jia Liu, Zhuo-Xuan Song, Meng Ye, Zhen-Han Li, Zhen-Rui Cao, Ying-Jiu Jiang, Hong-Tao Tie","doi":"10.31083/j.rcm2512453","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Coronary atherosclerosis serves as the primary pathological etiology underlying coronary artery disease (CAD). Thyroid hormones show potential as risk factors, aside from the main standard modifiable cardiovascular risk factors (SMuRFs). This research seeks to elucidate the link between thyroid activity and coronary atherosclerosis.</p><p><strong>Methods: </strong>Single nucleotide polymorphisms (SNPs) linked to hypothyroidism (N = 213,990), Graves' disease (GD) (N = 190,034), other hyperthyroidism types (N = 190,799), thyroid-stimulating hormone (TSH) (N = 271,040), free thyroxine (FT4) (N = 119,120), and coronary atherosclerosis (N = 360,950) were retrieved from the IEU OpenGWAS, Finngen R9, and ThyroidOmics Consortium databases. Following the application of strict criteria to eliminate linkage disequilibrium, palindromic sequences, and heterozygous alleles, a bidirectional Mendelian Randomization (MR) analysis was conducted between the thyroid gland and coronary atherosclerosis using inverse variance weighting (IVW), weighted median (WM), and MR-Egger techniques. For sensitivity analysis, Cochran's Q test, leave-one-out method, and MR-Egger regression analysis were employed.</p><p><strong>Results: </strong>The forward MR analysis indicates that genetic predispositions such as hypothyroidism (OR = 1.07; 95% CI 1.01-1.12; IVW-<i>p</i> = 0.021), Graves' disease (OR = 1.04; 95% CI 1.01-1.07; IVW-<i>p</i> = 0.002), and other forms of hyperthyroidism (OR = 1.05; 95% CI 1.01-1.10; IVW-<i>p</i> = 0.021) elevate the likelihood of developing coronary atherosclerosis. Additionally, no discernible evidence of a causality between FT4 or TSH, and coronary atherosclerosis (IVW-<i>p</i> > 0.05) was found. Coronary atherosclerosis is not related to increased risk of five thyroid function phenotypes in reverse MR analysis. The sensitivity analysis provided relatively reliable evidence to reinforce the validity of our findings.</p><p><strong>Conclusions: </strong>Our findings are an investigation of the causality between thyroid function and coronary atherosclerosis. This study pinpointed potential heart disease risks linked to coronary atherosclerosis and offered additional understanding for defining SMuRFs in CAD.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":"25 12","pages":"453"},"PeriodicalIF":1.9000,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11683704/pdf/","citationCount":"0","resultStr":"{\"title\":\"A Two-Way Mendelian Randomization Analysis on the Link between Thyroid Activity Function and Coronary Atherosclerosis.\",\"authors\":\"Le-Tai Li, Jia-Jie Leng, Yu-Xiang Luo, Rong-Jia Liu, Zhuo-Xuan Song, Meng Ye, Zhen-Han Li, Zhen-Rui Cao, Ying-Jiu Jiang, Hong-Tao Tie\",\"doi\":\"10.31083/j.rcm2512453\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Coronary atherosclerosis serves as the primary pathological etiology underlying coronary artery disease (CAD). Thyroid hormones show potential as risk factors, aside from the main standard modifiable cardiovascular risk factors (SMuRFs). This research seeks to elucidate the link between thyroid activity and coronary atherosclerosis.</p><p><strong>Methods: </strong>Single nucleotide polymorphisms (SNPs) linked to hypothyroidism (N = 213,990), Graves' disease (GD) (N = 190,034), other hyperthyroidism types (N = 190,799), thyroid-stimulating hormone (TSH) (N = 271,040), free thyroxine (FT4) (N = 119,120), and coronary atherosclerosis (N = 360,950) were retrieved from the IEU OpenGWAS, Finngen R9, and ThyroidOmics Consortium databases. Following the application of strict criteria to eliminate linkage disequilibrium, palindromic sequences, and heterozygous alleles, a bidirectional Mendelian Randomization (MR) analysis was conducted between the thyroid gland and coronary atherosclerosis using inverse variance weighting (IVW), weighted median (WM), and MR-Egger techniques. For sensitivity analysis, Cochran's Q test, leave-one-out method, and MR-Egger regression analysis were employed.</p><p><strong>Results: </strong>The forward MR analysis indicates that genetic predispositions such as hypothyroidism (OR = 1.07; 95% CI 1.01-1.12; IVW-<i>p</i> = 0.021), Graves' disease (OR = 1.04; 95% CI 1.01-1.07; IVW-<i>p</i> = 0.002), and other forms of hyperthyroidism (OR = 1.05; 95% CI 1.01-1.10; IVW-<i>p</i> = 0.021) elevate the likelihood of developing coronary atherosclerosis. Additionally, no discernible evidence of a causality between FT4 or TSH, and coronary atherosclerosis (IVW-<i>p</i> > 0.05) was found. Coronary atherosclerosis is not related to increased risk of five thyroid function phenotypes in reverse MR analysis. The sensitivity analysis provided relatively reliable evidence to reinforce the validity of our findings.</p><p><strong>Conclusions: </strong>Our findings are an investigation of the causality between thyroid function and coronary atherosclerosis. This study pinpointed potential heart disease risks linked to coronary atherosclerosis and offered additional understanding for defining SMuRFs in CAD.</p>\",\"PeriodicalId\":20989,\"journal\":{\"name\":\"Reviews in cardiovascular medicine\",\"volume\":\"25 12\",\"pages\":\"453\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-12-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11683704/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reviews in cardiovascular medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.31083/j.rcm2512453\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in cardiovascular medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31083/j.rcm2512453","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

简介:冠状动脉粥样硬化是冠心病的主要病理病因。甲状腺激素显示潜在的危险因素,除了主要的标准可变心血管危险因素(smurf)。本研究旨在阐明甲状腺活动与冠状动脉粥样硬化之间的联系。方法:从IEU OpenGWAS、Finngen R9和ThyroidOmics Consortium数据库中检索与甲状腺功能减退症(N = 213,990)、Graves病(N = 190,034)、其他甲状腺功能亢进类型(N = 190,799)、促甲状腺激素(TSH) (N = 271,040)、游离甲状腺素(FT4) (N = 119,120)和冠状动脉粥样硬化(N = 360,950)相关的单核苷酸多态性(snp)。在应用严格的标准来消除连锁不平衡、回文序列和杂合等位基因后,使用反方差加权(IVW)、加权中位数(WM)和MR- egger技术,在甲状腺和冠状动脉粥样硬化之间进行双向孟德尔随机化(MR)分析。敏感性分析采用Cochran’s Q检验、留一法和MR-Egger回归分析。结果:前向磁共振分析提示甲状腺功能减退等遗传易感性(OR = 1.07;95% ci 1.01-1.12;IVW-p = 0.021), Graves病(OR = 1.04;95% ci 1.01-1.07;IVW-p = 0.002)和其他形式的甲亢(OR = 1.05;95% ci 1.01-1.10;IVW-p = 0.021)升高发生冠状动脉粥样硬化的可能性。此外,没有明显的证据表明FT4或TSH与冠状动脉粥样硬化之间存在因果关系(IVW-p >.05)。反向磁共振分析显示,冠状动脉粥样硬化与五种甲状腺功能表型的风险增加无关。敏感性分析提供了相对可靠的证据,加强了我们研究结果的有效性。结论:我们的研究结果是对甲状腺功能与冠状动脉粥样硬化之间因果关系的调查。该研究明确了与冠状动脉粥样硬化相关的潜在心脏病风险,并为CAD中smurf的定义提供了额外的理解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Two-Way Mendelian Randomization Analysis on the Link between Thyroid Activity Function and Coronary Atherosclerosis.

Introduction: Coronary atherosclerosis serves as the primary pathological etiology underlying coronary artery disease (CAD). Thyroid hormones show potential as risk factors, aside from the main standard modifiable cardiovascular risk factors (SMuRFs). This research seeks to elucidate the link between thyroid activity and coronary atherosclerosis.

Methods: Single nucleotide polymorphisms (SNPs) linked to hypothyroidism (N = 213,990), Graves' disease (GD) (N = 190,034), other hyperthyroidism types (N = 190,799), thyroid-stimulating hormone (TSH) (N = 271,040), free thyroxine (FT4) (N = 119,120), and coronary atherosclerosis (N = 360,950) were retrieved from the IEU OpenGWAS, Finngen R9, and ThyroidOmics Consortium databases. Following the application of strict criteria to eliminate linkage disequilibrium, palindromic sequences, and heterozygous alleles, a bidirectional Mendelian Randomization (MR) analysis was conducted between the thyroid gland and coronary atherosclerosis using inverse variance weighting (IVW), weighted median (WM), and MR-Egger techniques. For sensitivity analysis, Cochran's Q test, leave-one-out method, and MR-Egger regression analysis were employed.

Results: The forward MR analysis indicates that genetic predispositions such as hypothyroidism (OR = 1.07; 95% CI 1.01-1.12; IVW-p = 0.021), Graves' disease (OR = 1.04; 95% CI 1.01-1.07; IVW-p = 0.002), and other forms of hyperthyroidism (OR = 1.05; 95% CI 1.01-1.10; IVW-p = 0.021) elevate the likelihood of developing coronary atherosclerosis. Additionally, no discernible evidence of a causality between FT4 or TSH, and coronary atherosclerosis (IVW-p > 0.05) was found. Coronary atherosclerosis is not related to increased risk of five thyroid function phenotypes in reverse MR analysis. The sensitivity analysis provided relatively reliable evidence to reinforce the validity of our findings.

Conclusions: Our findings are an investigation of the causality between thyroid function and coronary atherosclerosis. This study pinpointed potential heart disease risks linked to coronary atherosclerosis and offered additional understanding for defining SMuRFs in CAD.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Reviews in cardiovascular medicine
Reviews in cardiovascular medicine 医学-心血管系统
CiteScore
2.70
自引率
3.70%
发文量
377
审稿时长
1 months
期刊介绍: RCM is an international, peer-reviewed, open access journal. RCM publishes research articles, review papers and short communications on cardiovascular medicine as well as research on cardiovascular disease. We aim to provide a forum for publishing papers which explore the pathogenesis and promote the progression of cardiac and vascular diseases. We also seek to establish an interdisciplinary platform, focusing on translational issues, to facilitate the advancement of research, clinical treatment and diagnostic procedures. Heart surgery, cardiovascular imaging, risk factors and various clinical cardiac & vascular research will be considered.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信